KRAS and non-small cell lung carcinoma: Supplementation with GlcNAc as well as GlcN rescued cell proliferation and death induced by nutlin-3a (Fig. 6A, B), suggesting that the HBP is required for KRAS MT/p53 WT NSCLC cell viability.